Encompass Health Corp EHC
We take great care to ensure that the data presented and summarized in this overview for Encompass Health Corp is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding EHC
View all-
Vanguard Group Inc Valley Forge, PA10.4MShares$1.26 Billion0.02% of portfolio
-
Black Rock Inc. New York, NY9.05MShares$1.1 Billion0.02% of portfolio
-
Invesco Ltd. Atlanta, GA5.82MShares$706 Million0.12% of portfolio
-
Wellington Management Group LLP Boston, MA3.62MShares$439 Million0.07% of portfolio
-
State Street Corp Boston, MA3.18MShares$385 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD2.08MShares$252 Million0.14% of portfolio
-
Alliancebernstein L.P. New York, NY1.91MShares$232 Million0.07% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.87MShares$227 Million0.05% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.82MShares$221 Million0.02% of portfolio
-
Geode Capital Management, LLC Boston, MA1.76MShares$214 Million0.01% of portfolio
Latest Institutional Activity in EHC
Top Purchases
Top Sells
About EHC
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
Insider Transactions at EHC
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 20
2025
|
Mark J Tarr President & CEO |
SELL
Open market or private sale
|
Direct |
118,384
-9.17%
|
$14,324,464
$121.24 P/Share
|
|
May 20
2025
|
Mark J Tarr President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
118,384
+8.79%
|
$4,616,976
$39.87 P/Share
|
|
May 14
2025
|
Edmund Fay Sr. Vice Pres. and Treasurer |
SELL
Bona fide gift
|
Direct |
3,667
-3.66%
|
-
|
|
May 06
2025
|
Elissa Joy Charbonneau Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
4,279
-26.35%
|
$496,364
$116.61 P/Share
|
|
May 01
2025
|
Joan E Herman Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+2.9%
|
-
|
|
May 01
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+18.19%
|
-
|
|
May 01
2025
|
Greg D Carmichael Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+7.12%
|
-
|
|
May 01
2025
|
Kevin J. O'Connor Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+12.61%
|
-
|
|
May 01
2025
|
Patricia Anne Maryland Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+8.81%
|
-
|
|
May 01
2025
|
Leslye G Katz Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+2.9%
|
-
|
|
May 01
2025
|
Nancy M Schlichting Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+6.31%
|
-
|
|
May 01
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+8.98%
|
-
|
|
May 01
2025
|
Terrance Williams Director |
BUY
Grant, award, or other acquisition
|
Direct |
1,424
+8.62%
|
-
|
|
Apr 30
2025
|
Patrick William Tuer EVP, Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
5,984
+23.15%
|
-
|
|
Apr 29
2025
|
John Patrick Darby EVP, Gen Counsel & Secretary |
SELL
Open market or private sale
|
Direct |
10,000
-11.15%
|
$1,140,000
$114.79 P/Share
|
|
Apr 29
2025
|
John Patrick Darby EVP, Gen Counsel & Secretary |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+10.03%
|
$350,000
$35.06 P/Share
|
|
Apr 29
2025
|
Douglas E Coltharp EVP & Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
43,575
-16.21%
|
$5,011,125
$115.55 P/Share
|
|
Apr 29
2025
|
Douglas E Coltharp EVP & Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
43,575
+19.15%
|
$1,307,250
$31.0 P/Share
|
|
Apr 24
2025
|
Edward M Christie Iii Director |
BUY
Grant, award, or other acquisition
|
Direct |
268
+5.1%
|
$27,336
$102.56 P/Share
|
|
Apr 22
2025
|
Christopher R Reidy Director |
BUY
Grant, award, or other acquisition
|
Direct |
360
+2.69%
|
$35,280
$98.23 P/Share
|
Last 12 Months Summary
| Grant, award, or other acquisition | 46.5K shares |
|---|---|
| Bona fide gift | 65.2K shares |
| Exercise of conversion of derivative security | 184K shares |
| Small Acquisition | 7 shares |
| Payment of exercise price or tax liability | 72.9K shares |
|---|---|
| Bona fide gift | 68.9K shares |
| Open market or private sale | 194K shares |